The US company said that results from the Alpha-CORRECT trial saw its colon cancer diagnostic Oncodetect achieving a ...

New Evidence Validates Oncodetect's™ Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients ...

For cancer patients, support goes beyond medicine. The Arizona Foundation for Cancer offers non-medical support services to help patients navigate through every step.

Kate's statement after he Royal Marsden Hospital visit resonated strongly with me. Like Kate, I am - touch wood - in ...

Natera, Inc. , a global leader in cell-free DNA and genetic testing, today announced that the first set of abstracts have been released from several studies that will be shared at the American Society ...

Having raised AUD 53 million in equity funding in fiscal 2023, Polynovo is in a comfortable financial position with net cash of AUD 43 million as of June 2024. We do not expect Polynovo will need to ...

Jan. 13, 2025 — Scientists have found that a test to detect circulating tumor DNA can predict lung cancer ... Lung Cancer Test Predicts Survival in Early Stages Better Than Current Methods Jan ...

Pre And Post-Surgical Immunotherapy Improves Outcomes for Patients With Operable Lung Cancer May 15, 2024 — Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative ...

Results from Alpha-CORRECT, a study with one of the longest MRD surveillance monitoring periods to date, showed the Oncodetect test achieved 78% sensitivity at the post-surgical timepoint and 91% ...

For women undergoing breast reconstruction after mastectomy, older age is associated with small but significant increases in certain complications, reports a study in the January issue of Plastic ...